Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brexit: EMA To Bolster Regulatory Reserves Ahead Of Relocation

Executive Summary

European Medicines Agency head Guido Rasi explains the measures being taken to soften the blow of its departure from the UK, while a former health commissioner says that a decision needs to be taken as soon as possible on where the agency will be sited in order to ensure a smooth transition before Brexit.

You may also be interested in...



EMA Multinational Assessment Teams Move Into Post-Authorization After Delay

The scope of the European Medicines Agency’s multinational assessment team initiative was originally due to expand in April from the pre-authorization to the post-authorization phase. It will happen next month instead.

EMA’s Multinational Approach Brings All But Two Member States Into New Drug Assessor Fold

The multinational assessment team (MNAT) approach aimed to involve more EU member states in the evaluation of new medicines. EMA views it as a success, although only about 10% of marketing authorization applications submitted for initial evaluation in 2015 involved MNATs. It will shortly be expanded to certain post-authorization procedures and is being promoted as a tool that will help the agency deal with Brexit fallout.

Dutch Call For Early Decision On Location Of EMA And Say ‘Why Not Us?’

The Dutch government says it is well placed to host the European Medicines Agency, citing good travel links, the ability to host international organizations, and the prospect of continuity of the agency’s work. It wants a decision to be taken soon on the EMA’s future location.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS119492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel